----

----

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

———————

**FORM 10-Q**

———————

(Mark One)
|                                                                |                                                                                        |
|----------------------------------------------------------------|----------------------------------------------------------------------------------------|
| **X**                                                          | ** QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE**  |
|                                                           | ** ACT OF 1934**                                                                  |
| For the quarterly period ended: **December 31, 2009**          |
| Or                                                             |
|                                                           |                                                                                   |
|                                                           | ** TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE** |
|                                                           | ** ACT OF 1934**                                                                  |
| For the transition period from: _____________ to _____________ |

———————

**ADVANCED OXYGEN TECHNOLOGIES, INC.**

 (Exact name of registrant as specified in its charter)

———————
|                              |              |                     |
|------------------------------|--------------|---------------------|
| **Delaware**                 | **0-9951**   | **91-1143622**      |
| (State or Other Jurisdiction | (Commission  | (I.R.S. Employer    |
| of Incorporation)            | File Number) | Identification No.) |

**C/O Crossfield, Inc., 653 VT Route 12A, PO Box 189, Randolph VT, 05060**

 (Address of Principal Executive Offices) (Zip Code)

**(212) 727-7085**

 (Registrant’s telephone number, including area code)

**C/O Crossfield, Inc., 100 Maiden Lane, Suite 2003, New York, NY 10038**

(Former name, former address and former fiscal year, if changed since last report)

———————
|                                                                                                                                                                                                                                                                                                                                               |        |           |        |                           |        |        |  |  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------|--------|---------------------------|--------|--------|--|--|
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the								Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was                                                                                          |
| required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                                                                                                                                                                                    | X      |  Yes |   |  No                  |
|                                                                                                                                                                                                                                                                                                                                          |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. |
|                                                                                                                                                                                                                                                                                                                                          |   |
| Large accelerated filer                                                                                                                                                                                                                                                                                                                       |   |      |   | Accelerated filer         |   |   |
| Non-accelerated filer                                                                                                                                                                                                                                                                                                                         |   |      |   | Smaller reporting company | X      |   |
| (Do not check if a smaller reporting company)                                                                                                                                                                                                                                                                                                 |   |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).                                                                                                                                                                                                                                       |   |  Yes | X      |  No                  |
|                                                                                                                                                                                                                                                                                                                                          |   |
| Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:                                                                                                                                                                                                      |
| As of February 5, 2010, there were 46,973,585 issued shares and 45,853,585 outstanding shares of Advanced Oxygen Technologies, Inc. common stock, $0.01 par value.                                                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                          |

----

----

**ADVANCED OXYGEN TECHNOLOGIES, INC.**

 Table of Contents

|                                                      |                                                                                               | INDEX                                                                                                                                                                  |
|------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PART I                                               |                                                                                               |                                                                                                                                                                        |
|                                                      | Item I: Financial Statements (unaudited)                                                      |                                                                                                                                                                        | Page |
|                                                      |                                                                                               | Unaudited consolidated Balance Sheet as of December 31, 2009 and June 30, 2009                                                                                         |  | 1 |
|                                                      |                                                                                               | Unaudited Consolidated Statement of Operations and Changes in Accumulated Deficit for the three months and Six months ended December 31, 2009 and December 31, 2008    |  | 3 |
|                                                      |                                                                                               | Unaudited Consolidated Statement of Changes in Stockholders’ Equity and (Capital Deficiency) for the three months ended December 31, 2009 and December 31, 2008 |  | 4 |
|                                                      |                                                                                               | Unaudited Consolidated Statement of Cash Flow for the three months ended December 31, 2009 and December 31, 2008                                                       |  | 5 |
|                                                      |                                                                                               | Notes to the Consolidated Financial Statements                                                                                                                         |  | 6 |
|                                                      | Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations |                                                                                                                                                                        | 11 |
|                                                      | Item 3: Quantitative and Qualitative Disclosures about Market Risk                            |                                                                                                                                                                        | 16 |
|                                                      | Item 4T: Controls and Procedures                                                              |                                                                                                                                                                        | 16 |
| PART II                                              |                                                                                               |                                                                                                                                                                        |
|                                                      | Item 1: Legal Proceedings                                                                     |                                                                                                                                                                        | 18 |
|                                                      | Item 2: Unregistered Sales of Equity Securities and Use of Proceeds                           |                                                                                                                                                                        | 18 |
|                                                      | Item 3: Defaults Upon Senior Securities                                                       |                                                                                                                                                                        | 18 |
|                                                      | Item 4: Submission of Matters To a Vote of Security Holders                                   |                                                                                                                                                                        | 18 |
|                                                      | Item 5: Other Information                                                                     |                                                                                                                                                                        | 18 |
|                                                      | Item 6. Exhibits and Reports on Form 8-K                                                      |                                                                                                                                                                        | 18 |
| Signature                                            |                                                                                               | 19                                                                                                                                                                     |
| EXHIBIT 99.1 (A), 99.1(B) Certifications of Officers |                                                                                               | EX 31                                                                                                                                                                  |
| EXHIBIT 99.1 (C), 99.1(D) Certifications of Officers |                                                                                               | EX 32                                                                                                                                                                  |
|                                                      |                                                                                               |                                                                                                                                                                   |  |   |

----

**PART 1: FINANCIAL INFORMATION**

| ** ADVANCED OXYGEN TECHNOLOGIES, INC.**
**AND SUBSIDIARY**

**CONSOLATED BALANCE SHEETS**                                                                                     |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                    | **December 31, 2009** | **June 30, 2009** |
| **ASSETS**                                                                                                                                                                         | **Unaudited  ****** | **Audited  ****** |
|                                                                                                                                                                               |  |  |
| CURRENT ASSETS                                                                                                                                                                     |  |  |
|    Cash                                                                                                                                                                  | $       42,331 | $       31,268 |
|    Accounts Receivable                                                                                                                                                   | 5,283 | 5,283 |
|    Other Current Assets                                                                                                                                                  | - | - |
|                                                                                                                                                                               | ------------ | ------------ |
|    Total Current Assets                                                                                                                                             | 47,614 | 36,551 |
|                                                                                                                                                                               |  |  |
| FIXED ASSETS                                                                                                                                                                       |  |  |
| Land and buildings                                                                                                                                                                 | 650,000 | 650,000 |
|                                                                                                                                                                               | ------------ | ------------ |
| **TOTAL ASSETS**                                                                                                                                                                   | **$    697,614** | **$    686,551** |
|                                                                                                                                                                               | ============ | ============ |
|                                                                                                                                                                                    |
|   **LIABILITIES AND STOCKHOLDERS' DEFICIENCY  **                                                                                                                         |  |  |
| CURRENT LIABILITIES                                                                                                                                                                |  |  |
|   Accounts payable                                                                                                                                                       | $    21,791 | $    24,389 |
|   Current Portion of Long Term Debt                                                                                                                                           | 7,011 | 7,011 |
|   Note Payable                                                                                                                                                                | 177,000 | 177,000 |
|   Payroll and sales taxes payable                                                                                                                                        | 46,827 | 42,115 |
|   Prepaid Rental Revenues                                                                                                                                                | 18,781 | 14,883 |
|                                                                                                                                                                               | ------------ | ------------ |
| Total current liabilities                                                                                                                                                          | 271,410 | 265,398 |
|                                                                                                                                                                               |  |  |
|    Long Term Debt, subsidiary                                                                                                                                            | 85,097 | 86,902 |
|    Due to affiliate                                                                                                                                                      | 38,665 | 38,015 |
|                                                                                                                                                                               | ------------ | ------------ |
| Total Long Term Debt                                                                                                                                                               | 123,762 | 124,917 |
|                                                                                                                                                                               |  |  |
| Total Liabilities                                                                                                                                                                  | 395,172 | 390,315 |
|                                                                                                                                                                               |  |  |
| STOCKHOLDERS' DEFICIENCY -                                                                                                                                                         |  |  |
|    Convertible preferred stock, Series 2, par value $0.01; authorized  10,000,000 shares; issued and outstanding 5,000 shares liquidating preference $25,000   | 50 | 50 |
|                                                                                                                                                                               |  |  |
|    Convertible preferred stock, Series 3, par value $0.01; authorized and issued, 1,670,000 shares                                                                       | 16,700 | 16,700 |
|                                                                                                                                                                               |  |  |
|    Convertible preferred stock, Series 4; issued and outstanding,                                                                                                        | - | - |
|                                                                                                                                                                               |  |  |
|    Convertible preferred stock, Series 5; issued, 1 share                                                                                                                | - | - |
|                                                                                                                                                                               |  |  |
|    Common stock, par value $0.01; authorized, 90,000,000 shares; issued 46,973,585 shares                                                                                | 469,736 | 469,736 |
|                                                                                                                                                                               |  |  |
|    Additional paid-in capital                                                                                                                                            | 20,497,769 | 20,497,769 |
|                                                                                                                                                                               |  |  |
|    Accumulated deficit                                                                                                                                                   | (20,674,529) | (20,680,735) |
|                                                                                                                                                                               |  |  |
|    Less treasury stock, at cost                                                                                                                                          |  |  |
|       1,670,000 shares of convertible preferred   stock, Series 3                                                                                         | (7,284) | (7,284) |
|       1,120,000 shares of common stock                                                                                                                         | - | - |
|                                                                                                                                                                |  |  |
| **  TOTAL SHAREHOLDERS EQUITY**                                                                                                                                          | **302,442** | **296,236** |
|                                                                                                                                                                                    | ------------ | ------------ |
| **  TOTAL LIABILITIES AND SHAREHOLDERS EQUITY**                                                                                                                          | **$    697,614** | **$    686,551** |
|                                                                                                                                                                                    | ============ | ============ |
| **See accompanying notes to financial statements.**                                                                                                                                |

**Return to Table of Contents**

----

| **ADVANCED OXYGEN TECHNOLOGIES, INC.**                                      |
|-----------------------------------------------------------------------------|
| **Consolidated Statement of Operations and Changes in Accumulated Deficit** |
|                                                                             |  |  |  |  |
|                                                                             | 3 Month Period Ending December, 31 | 6 Month Period Ending December 31, |
|                                                                             | **(Unaudited)** | **(Unaudited)** |
|                                                                        | **2009** | **2008** | **2009** | **2008** |
| Revenues                                                                    |  |  |  |  |
| Real Estate Rental Income, subsidiary                                       | 10,078 | 9,375 | 19,681 | 19,278 |
| Total Revenues                                                              | 10,078 | 9,375 | 19,681 | 19,278 |
|                                                                        |  |  |  |  |
| Cost of Sales                                                               |  |  |  |  |
| Cost of Sales, subsidiary                                                   | - | - | - | - |
|                                                                        | ======== | ======== | ======== | ======== |
| Gross Profit                                                                | 10,078 | 9,375 | 19,681 | 19,278 |
|                                                                        |  |  |  |  |
| Expenses                                                                    |  |  |  |  |
| Accounting Expense                                                          | 5,977 | - | 5,977 | - |
| Interest Expense                                                            | 1,666 | 1,692 | 3,339 | 3,544 |
| General & Administrative                                                | 379 | 753 | 4,173 | 4,774 |
| Transfer Agent Expense                                                      | - | - | - | 25 |
| Total Expenses                                                              | 8,022 | 2,445 | 13,489 | 8,343 |
|                                                                             | ======== | ======== | ======== | ======== |
| **Income (loss) from Operations**                                           | 2,056 | 6,930 | 6,192 | 10,935 |
|                                                                        |  |  |  |  |
| Other Income (Expense)                                                      |  |  |  |  |
| Interest Income                                                             | - | - | 14 | 1,076 |
| Gain (loss) on Sale of Asset                                                | - | - | - | - |
| Total Other Income (Expense)                                                | - | - | 14 | 1,076 |
|                                                                        | ======== | ======== | ======== | ======== |
| **Net Income (Loss)**                                                       | **2,056** | **6,930** | **6,206** | **12,011** |
|                                                                        |  |  |  |  |
| Accumulated Deficit                                                         |  |  |  |  |
| Beginning of Period                                                         | (20,676,585) | (20,747,781) | (20,680,735) | (20,752,862) |
| End of Period                                                               | (20,674,529) | (20,740,851) | (20,674,529) | (20,740,851) |
|                                                                        |  |  |  |  |
| Earnings per Share                                                          | 0.000 | 0.000 | 0.000 | 0.000 |
| **See accompanying notes to financial statements.**                         |

**Return to Table of Contents**

----

| **ADVANCED OXYGEN TECHNOLOGIES, INC.**

**AND SUBSIDIARY**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY)** |
|------------------------------------------------------------------------------------------------------------------------------|
| ** **                                                                                                                   |  | ** ** |
| ** **                                                                                                                   | **6 Months ending** | **Year Ending** |
|                                                                                                                         | **December 31, 2009** | **June 30, 2009** |
|                                                                                                                         | **Unaudited** | **Audited** |
| **Common stock, par value $0.01, authorized, 90,000,000 shares;**                                                            | ------------- | ------------- |
|  **issued, as follows:**                                                                                                |  |   |
|     Balance at beginning and end of period 46,973,585                                                    | $  469,736 | $  469,736 |
|                                                                                                                         | ============= | ============= |
| **Additional paid in capital:**                                                                                              |  |   |
|     Balance at beginning and end of period                                                               | $  20,497,769 | $  20,497,769 |
|                                                                                                                         | ============= | ============= |
| **Accumulated deficit:**                                                                                                     |  |   |
|     Balance at beginning of period                                                                       | $  (20,680,735) | $  (20,752,862) |
|     Net income (loss) for the period                                                                     | 6,206 | 72,127 |
|                                                                                                                         | ------------- | ------------- |
|     Balance at end of period                                                                   | $  (20,674,529) | $  (20,680,735) |
|                                                                                                                              |  |  |
| **Rounding:**                                                                                                                | - | - |
|                                                                                                                         | ============= | ============= |
| **Other stockholders' deficiency accounts (no change during period**)                                                        |  |   |
|     Convertible preferred stock, net of treasury stock (see balance sheet )                              | $  9,466 | $  9,466 |
|                                                                                                                         | ============= | ============= |
| **Stockholders' Equity (Deficiency) at end of period**                                                                       | $  302,442 | $  296,236 |
|                                                                                                                         | ============= | ============= |
| **See accompanying notes to financial statements.**                                                                          |

**Return to Table of Contents**

----

| **ADVANCED OXYGEN TECHNOLOGIES, INC.**                           |
|------------------------------------------------------------------|
| **Consolidated Statement of Cash Flow **                    |
|                                                                  |  |  |  |  |
|                                                                  | 3 Month Period Ending December 31, | 6 Month Period Ending December 31, |
|                                                             | **(unaudited)** | **(unaudited)** |
|                                                             | **2009** | **2008** | **2009** | **2008** |
| **Cash flow from operating activities**                          |  |  |  |  |
| Net Income (Loss)                                                | 2,056 | 6,930 | 6,206 | 12,011 |
|                                                             |  |  |  |  |
| Adjustments to reconcile net loss to cash provided by operations |  |  |  |  |
| Accounts Receivable & Value Added Tax Receivable             | - | - | - | - |
| Accounts Payable and Accrued Expenses                            | (1,948) | - | (2,598) | (5,998) |
| Taxes Payable                                                    | (2,710) | (3,943) | 4,712 | 5,058 |
| Current Portion of Long Term Debt                                | - | - | - | - |
| Client Escrow Funds, ANV                                         | - | - | - | - |
| Prepaid Rental Revenues, ANV                                     | - | 4,451 | 3,898 | 25,875 |
| Total Adjustments                                                | (4,659) | 508 | 6,012 | 24,935 |
|                                                                  |  |  |  |  |
| Net Cash provided (used) by operations                           | (2,602) | 7,438 | 12,218 | 36,946 |
|                                                             |  |  |  |  |
| **Cash Flows from financing activities:**                        |  |  |  |  |
| Proceeds From:                                                   |  |  |  |  |
| Note Payable Crossfield:                                         | - | - | 650 | 2,080 |
| Used For:                                                        |  |  | - |  |
| Long Term Debt, Subsidiary                                       | - | (1,694) | (1,805) | (3,486) |
| **Net Cash Flows used in Financing Activities:**                 | - | (1,694) | (1,155) | (1,406) |
|                                                             |  |  |  |  |
| **Net Increase (decrease) in Cash**                              | **(2,602)** | **5,744** | **11,063** | **35,540** |
|                                                             |  |  |  |  |
| **Cash Balance at beginning of Period**                          | 44,933 | 163,758 | 31,268 | 133,962 |
| **Cash Balance at End of Period**                                | 42,331 | 169,502 | 42,331 | 169,502 |
|                                                             |  |  |  |  |
|  **See accompanying notes to financial statements.**        |

**Return to Table of Contents**

----

**NOTE 1- ORGANIZATION AND LINE OF BUSINESS*******Organization:*

Advanced Oxygen Technologies, Inc. (formerly Aquanautic Corporation) (the "Company") was a specialty materials company in the development stage (as defined by the Financial Accounting Standards Board ("FASB") in Statement of Financial Accounting Standards ("SFAS") no. 7, "Accounting and Reporting by Development Stage Enterprises"). The Company's core technology consisted of a variety of materials, which have a high affinity for oxygen. Through 1993 the Company also conducted research through funding from various government agencies such as the office of Naval Research and from Small Business Innovative Research ("SBIR") grants, as well as through its own internally generated funds.

The Company has agreed to indemnify Grace for any out of pocket costs incurred because of the claims, litigation, arbitration, or other proceedings (a) relating to the validity or ownership of the Patent Rights, (b) relating to any infringement by the Patent Rights of any other patent or trademark owned by a third party, (c) relating to any breach by the Company of its representations, warranties, covenants in the Purchase Agreement, or (d) arising from any state of affairs existing at closing which was not this indemnity. The indemnity is for all such costs up to $75,000 and for 50% of such costs over $75,000. Amounts due Grace under the indemnity would be paid by withholding royalties from the Company.The Company ceased its previous operations described above during 1995 and had dormant operations until March 1998. During 1997, the Company entered into the following agreements in preparation of starting a new line of business:Stock Acquisition Agreement:

Pursuant to a Stock Acquisition dated as of December 18, 1997, the Company issued 23,750,000 shares of its common stock, par value $0.01 per share, to several investors for $60,000 in cash, plus consulting services with a fair value of $177,500. In December, 2000 an affiliated creditor received $125,000 to reduce the Company's debt from an unrelated buyer of 3,000,000 shares of common stock which the Company issued during the yearOn March 9, 1998, pursuant to an Agreement of Purchase and Sale of Specified Business Assets ("Purchase Agreement"), a Promissory Note, and a Security Agreement, the Company purchased certain tangible and intangible assets (the "Assets"), including goodwill and rights under certain contracts from Integrated Marketing Agency, Inc. ("IMA"). The assets purchased from IMA consisted primarily of furniture, fixtures, equipment, computers, servers, software, and databases previously used by IMA in its full-service telemarketing business. The purchase price consisted of (a) a cash down payment of $10,000, (b) a note payable of $550,000, and (c) 1,670,000 shares of the Company's Series 3 convertible preferred stock. As described in Note 10, the preferred shares automatically convert into the Company's common shares on March 2, 2000 in a manner that depends on the value of the common stock during the ten trading days immediately prior to March 1, 2000. However, as part of the Purchase Agreement, IMA has the option to redeem the converted shares for the aggregate sum of $500,000 by delivering written notice to redeem the converted shares within ten business days after the conversion date. At the time of the purchase, the fair value of the preferred shares was not clearly evident, even though it appeared to be less than $500,000. Therefore, the purchase price had a fair value of at least $1,060,000. The assets purchased were recorded based upon their fair values.Pursuant to a Purchase Agreement dated January 28, 1999, the Company purchased the 1,670,000 shares of the Series 3 convertible preferred stock and the promissory note discussed in the preceding paragraph. As part of the agreement, the Company paid $15,000 to IMA, assumed a certain computer equipment lease with remaining obligations totaling $44,811 and executed a one-year $5,000 promissory note to IMA. In addition, both IMA and the Company provided mutual liability releases to each other.On March 5, 2003, the Company, in exchange for 14,000,000 common shares, acquired the common stock of IP Service Aps("IP") a Danish corporation which developed and sells a software package "Analizt". Analizt is a security early warning tool used by network administrators in order for them to implement security patches on software installations. The product is sold as installed software together with a subscription for information updates for the security database. The common shares issued at the date of acquisition were valued at 2 cents per share assigned entirely to software costs, an intangible asset, which has no fixed determinable life. This asset is evaluated at least annually and any decline in value is charged to operations during that year.

Return to Table of Contents

----

				On April 23, 2005 Mobile Group Inc., a formerly fully owned subsidiary of Advanced Oxygen Technologies, Inc., acquired 100% of the issued and outstanding stock of Mobiligroup, ApS from all of its owners in exchange for 80% of its stock. The Company will account for the investment of 20% of Mobile Group Inc. by the equity method.

Purchase of Anton Nielsen Vojens ApS: On February 3, 2006 Advanced Oxygen Technologies, Inc. ("AOXY") purchased 100.00% of the stock of Anton Nielsen Vojens ApS ("ANV"), a Danish company from Borkwood Development Ltd. (a previous shareholder of AOXY) for Six Hundred and Fifty Thousand US Dollars. The transaction was financed as follows: 1) AOXY executed a promissory note ("Note") for $650,000, payable to the sellers of ANV ("Sellers") payable and amortized monthly and carrying a interest at 5% per year. AOXY has the right to prepay the note at any time with a notice of 14 days. To secure the payment of principal and interest the Sellers will receive a perfect lien and security interest in the Shares in the company ANV until the note with accrued interest is paid in full., and, 2) In the case that the Note has not been repaid within 12 months from the day of closing the Sellers have the right to convert the debt to common stock of Advanced Oxygen Technologies, Inc. in an amount of non diluted shares calculated on the conversion Date, equal to the lesser of : a) Six hundred and Fifty thousand (650,000) or the Purchase Price minus the principal payments made by the buyer, which ever is greater, divided by the previous ten day closing price of AOXY as quoted on the national exchange, or b) Fifteen million shares, which ever is lesser.

Subdivision and Sale of ANV Real Estate: Pursuant to an acquisition agreement ("Acquisition Agreement"), on March 3, 2006 Anton Nielsen Vojens ApS ("ANV"), a wholly owned subsidiary of Advanced Oxygen Technologies, Inc. ("AOXY") entered into an agreement to sub divide and sell a 3,300 M2 portion of its Vojens City property ('Property") for Two Million Three hundred Thousand Danish Krone (2.300.000 DKk) to Ejendomsselskabet Ostergade 67 ApS, a Danish company ("EO").

*Lines of Business:*

The Company through its wholly owned subsidiary ANV owns income producing commercial real estate leased to Statoil AS until 2026.

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:***Revenue Recognition*:

*Recognition of rental income:*

Rental income for commercial property leases is recognized on a straight-line basis over the respective lease terms.

**Return to Table of Contents**
Sales of real estate are recognized when and to the extent permitted by Statement of Financial Accounting Standards No. 66, “Accounting for Sales of Real Estate” (“SFAS No. 66”), as amended by SFAS No. 144. Until the requirements of SFAS No. 66 for full profit recognition have been met, transactions are accounted for using either the deposit, the installment, the cost recovery, or the financing method, whichever is appropriate.
*Interest Recognition on Notes Receivable*
Interest income is not recognized on notes receivable that have been delinquent for 60 days or more. In addition, accrued but unpaid interest income is only recognized to the extent that the net realizable value of the underlying collateral exceeds the carrying value of the receivable.

*Foreign currency translation:*

Foreign currency transactions are translated applying the current rate method. Assets and liabilities are translated at current rates. Stockholders' equity accounts are translated at the appropriate historical rates and revenue and expenses are translated at weighted average rates for the year. Exchange rate differences that arise between the rate at the transaction date and the one in effect at the payment date, or at the balance sheet date, are recognized in the income statement.*Income Taxes:*

The Company accounts for income taxes under the asset and liability method of accounting. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is required when it is less likely than not that the Company will be able to realize all or a portion of its deferred tax assets. Because it is doubtful that the net operating losses of recent years will ever be used, a valuation allowance has been recognized equal to the tax benefit of net operating losses generated.*Net Earnings per Share:*

The Company adopted SFAS No. 128, "Earnings per Share". Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.*Cash and Cash Equivalents:*

For purposes of the statement of cash flows, the Company considers all highly-liquid investments purchased with original maturities of three months or less to be cash equivalents.The Company maintains its cash in bank deposit accounts which, at December 31, 2009 did not exceed federally insured limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on such amounts.*Estimates:*

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.*****Concentrations of Credit Risk:*

Financial instruments that potentially subject the Company to major credit risk consist principally of a single subsidiary of Anton Nielsen Vojens ApS and its customer concentration.
**Return to Table of Contents**
*Recently Issued Accounting Standards*

In February 2006, the FASB issued SFAS No. 155, “Accounting for Certain Hybrid Financial Instruments—an Amendment of FASB Statements No. 133 and 140” (“SFAS No. 155”). The purpose of SFAS No. 155 is to simplify the accounting for certain hybrid financial instruments by permitting fair value re-measurement for any hybrid financial instrument that contains an embedded derivative that otherwise would require bifurcation. SFAS No. 155 is effective for all financial instruments acquired or issued after the beginning of an entity’s first fiscal year that begins after September 15, 2006. The Company does not expect the adoption of SFAS No. 155 to have a material impact on its cash flows, results of operations, financial position or liquidity.

In March 2006, the FASB issued SFAS No. 156, “Accounting for Servicing of Financial Assets—an Amendment of FASB Statement No. 140” (“SFAS No. 156”). SFAS No. 156 requires recognition of a servicing asset or a servicing liability each time an entity undertakes an obligation to service a financial asset by entering into a servicing contract. SFAS No. 156 also requires that all separately recognized servicing assets and servicing liabilities be initially measured at fair value and subsequently measured at fair value at each reporting date. SFAS No. 156 is effective as of the beginning of any entity’s first fiscal year that begins after September 15, 2006. The Company does not expect the adoption of SFAS No. 156 to have a material impact on its cash flows, results of operations, financial position or liquidity.

In June 2006, FASB issued FIN No. 48, “Accounting for Uncertainty Taxes”. The interpretation applies to all tax positions related to income taxes subject to FASB Statement No. 109, “Accounting for Income Taxes”. FIN No. 48 clarifies the accounting for uncertainty in income taxes by prescribing a minimum recognition threshold in determining if a tax position should be reflected in the financial statements. Only tax positions that meet the “more likely than not” recognition threshold may be recognized. The interpretation also provides guidance on classification, interest and penalties, accounting in interim periods, disclosure, and transition requirements for uncertain tax positions. FIN No. 48 will be effective for the Company’s fiscal year ending June 30, 2007. The Company does not believe that there are material tax positions that would result in a material impact upon implementation of FIN No. 48.In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements”. This standard establishes a single authoritative definition of fair value, sets out a framework for measuring fair value and expands disclosures about fair value measurements. SFAS No. 157 applies to fair value measurements already required or permitted by existing standards. SFAS No. 157 will be effective for the Company’s fiscal year ending June 30, 2009. The Company is currently evaluating the requirements of SFAS No. 157 and has not yet determined the impact on its financial condition and results of operations.

In September 2006, the FASB issued SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and other Postretirement Plans - an amendment of FASB Statement No. 87, 88, 106 and 132R”. This pronouncement requires an employer to make certain recognitions, measurements, and disclosures regarding defined benefit postretirement plans. The Company does not have any defined benefit postretirement plans and SFAS No. 158 will not have any impact on its financial condition and results of operations.

In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 108 “Considering the Effects of Prior Year Misstatements in Current Year Financial Statements” (“SAB 108”). SAB 108 provides guidance on consideration of the effects of prior year misstatements in quantifying current year misstatements for the purpose of a materiality assessment. SAB 108 is effective for fiscal years ending after November 15, 2006. The adoption of SAB 108 did not have an impact on the Company’s consolidated financial statements.In February 2007, the FASB issued SFAS No 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”) which permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 will be effective for us on July 1, 2008. The Company is currently evaluating the impact of adopting SFAS 159 on its financial position, cash flows and results of operations.

**N****OTE 3 - MAJOR CUSTOMER:**

The Company's subsidiary, Anton Nielsen Vojens, ApS has sales to two major customers who were non related parts. For the period ending December 31, 2009, June 30, 2009, and June 30, 2008 the major customer concentrations were as follows: ****

**Return to Table of Contents**
**Percent of Sales****for the Period ending****December 31,****June 30,****Customer****2009****2009****2008**A100%100%100%B0%0%0%**Total Sales from Major Customers****100%****100%****100%**
**NOTE 4 - RELATED PARTY TRANSACTIONS ANTON NIELSEN VOJENS, ApS******The Company purchased Anton Nielsen Vojens ApS from a previous shareholder of the Company, Borkwood Development LTD ("Borkwood"). At the time of the acquisition, even though Borkwood was not a shareholder, a director of Borkwood was an officer of Anton Nielsen Vojens ApS who has since terminated his association with the Company.

**NOTE 5 - **COMMITMENTS AND CONTINGENCIES:****

*Commitments*:

The Company has issued a promissory note ("Note") for $650,000, payable to the Borkwood Development Ltd, a previous shareholder of the Company ("Seller"), payable and amortized monthly and carrying a interest at 5% per year. The Company has the right to prepay the note at any time with a notice of 14 days. To secure the payment of principal and interest the Sellers will receive a perfect lien and security interest in the Shares in the company ANV until the note with accrued interest is paid in full., and, 2) In the case that the Note has not been repaid within 12 months from the day of closing the Sellers have the right to convert the debt to common stock of Advanced Oxygen Technologies, Inc. in an amount of non diluted shares calculated on the conversion Date, equal to the lesser of : a) Six hundred and Fifty thousand (650,000) or the Purchase Price minus the principal payments made by the buyer, which ever is greater, divided by the previous ten day closing price of AOXY as quoted on the national exchange, or b) Fifteen million shares, which ever is lesser. The Note has been extended until July 1, 2010 and interest waived through the period ending June 30, 2009.

The Company's wholly owned subsidiary Anton Nielsen Vojens, ApS has a note payable with a bank. The original amount of the note was kr 750,000 Danish Krone (kr). The note is unsecured and uncollateralized, with a 7.00% interest rate and a 9 years left on the term. The balances on the note as of December 31, 2009 and December 31, 2008 were $92,108 and $108,241 respectively and the yearly payments are fixed at kr 75,000.

**NOTE 6 - DUE TO AFFILIATE**

*Due to affiliate consisted of:*

1) Advances payable to Crossfields, Inc., a related party, which are not collateralized, non-interest bearing, and payable upon demand, however, the Company did not expect to make payment within one year. During the 3 month period ended December 31, 2009 and 2008 the Company had borrowed nothing for both periods and had balances of $38,655 and $37,765 respectively, from affiliates and officers to meet expenses. The balances were not collateralized, were non-interest bearing and were payable on demand. 

**NOTE 7 -****INCOME TAXES**As of December 31, 2009, the Company had federal and state net operating loss carryforwards of approximately $12,400,000 of which approximately $1,600,000 may be utilized to offset future taxable income. Section 382 of the Internal Revenue Code imposes substantial restrictions on the utilization of net operating loss and tax credit carryforwards when a change in ownership occurs. No deferred tax debits have been recorded because it is considered unlikely that they will be realized. The loss carryforwards will expire during the fiscal years ended June 30 as follows:

**Return to Table of Contents**

****
YearAmount2012$464,0002018236,0002019548,0002020351,000202129,000Total$ 1,628,000
The overall effective tax rate differs from the federal statutory tax rate of 34% due to operating losses and other deferred assets not providing benefit for income tax purposes.

**NOTE 8 - SHAREHOLDERS' EQUITY:**

Preferred Stock:

The Company is authorized to issue 10,000,000 shares of $0.01 par value preferred stock. The Company may issue any class of preferred shares in series. The board of directors has the authority to establish and designate series and to fix the number of shares included in each such series.

Series 2 Convertible Preferred Stock:

Each Series 2 preferred share is convertible into two shares of common stock at the option of the holder. Each Series 2 preferred share also includes one warrant to purchase two common shares for $5.00. The warrants are exercisable over a three-year period. In the event of the liquidation of the Company, holders of Series 2 preferred stock would be entitled to receive $5.00 per share, plus any unpaid dividends declared on the Series 2 preferred stock from the funds remaining after the Company's creditors, including directors, have been paid. There have been no dividends declared.

During November 1997, 172,000 shares of Series 2 preferred stock were converted into 344,000 shares of the Company's common stock.

Series 4 Convertible Preferred Stock:

The shares are collectively convertible to common stock of the Company on March 5, 2004, in an amount equal to the greater of a.)290,000 shares divided by the ten day closing price, prior to the date of acquisition of IPS, of the Company's common stock as quoted on the national exchange and not to exceed twenty million shares, or b.) six million shares.

******ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**

The following should be read in conjunction with our Consolidated Financial Statements and the notes thereto included in the Financial Statements."

FORWARD LOOKING STATEMENTS: 

Certain statements contained in this report, including statements concerning the Company's future and financing requirements, the Company's ability to obtain market acceptance of its products and the competitive market for sales of small production business' and other statements contained herein regarding matters that are not historical facts, are forward looking statements; actual results may differ materially from those set forth in the forward looking statements, which statements involve risks and uncertainties, including without limitation to those risks and uncertainties set forth in any of the Company's Registration Statements under the heading "Risk Factors" or any other such heading. In addition, historical performance of the Company should not be considered as an indicator for future performance, and as such, the future performance of the Company may differ significantly from historical performance. 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

**Return to Table of Contents**The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. (“GAAP”) requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Following are accounting policies that we believe are most important to the portrayal of our financial condition and results of operations and that require our most difficult judgments as a result of the need to make estimates and assumptions about the effects of matters that are inherently uncertain.

*Recognition of rental income.*

Rental income for commercial property leases is recognized on a straight-line basis over the respective lease terms.

*Revenue recognition on the sale of real estate.*

Sales of real estate are recognized when and to the extent permitted by Statement of Financial Accounting Standards No. 66, “Accounting for Sales of Real Estate” (“SFAS No. 66”), as amended by SFAS No. 144. Until the requirements of SFAS No. 66 for full profit recognition have been met, transactions are accounted for using either the deposit, the installment, the cost recovery, or the financing method, whichever is appropriate.

Interest Recognition on Notes Receivable

Interest income is not recognized on notes receivable that have been delinquent for 60 days or more. In addition, accrued but unpaid interest income is only recognized to the extent that the net realizable value of the underlying collateral exceeds the carrying value of the receivable.

*Foreign currency translation:*

Foreign currency transactions are translated applying the current rate method. Assets and liabilities are translated at current rates. Stockholders' equity accounts are translated at the appropriate historical rates and revenue and expenses are translated at weighted average rates for the year. Exchange rate differences that arise between the rate at the transaction date and the one in effect at the payment date, or at the balance sheet date, are recognized in the income statement.

*Income Taxes:*

The Company accounts for income taxes under the asset and liability method of accounting. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is 

required when it is less likely than not that the Company will be able to realize all or a portion of its deferred tax assets. Because it is doubtful that the net operating losses of recent years will ever be used, a valuation allowance has been recognized equal to the tax benefit of net operating losses generated.

*Net Earnings per Share:*

The Company adopted SFAS No. 128, "Earnings per Share". Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

*Cash and Cash Equivalents:*

For purposes of the statement of cash flows, the Company considers all highly-liquid investments purchased with original maturities of three months or less to be cash equivalents.

**Return to Table of Contents**

The Company maintains its cash in bank deposit accounts which, at December 31, 2009 did not exceed federally insured limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on such amounts.

*Estimates:*

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.

*Concentrations of Credit Risk*:

Financial instruments that potentially subject the Company to major credit risk consist principally of a single subsidiary of Anton Nielsen Vojens ApS and its customer concentration.

*Recently Issued Accounting Standards*

In February 2006, the FASB issued SFAS No. 155, “Accounting for Certain Hybrid Financial Instruments—an Amendment of FASB Statements No. 133 and 140” (“SFAS No. 155”). The purpose of SFAS No. 155 is to simplify the accounting for certain hybrid financial instruments by permitting fair value re-measurement for any hybrid financial instrument that contains an embedded derivative that otherwise would require bifurcation. SFAS No. 155 is effective for all financial instruments acquired or issued after the beginning of an entity’s first fiscal year that begins after September 15, 2006. We do not expect the adoption of SFAS No. 155 to have a material impact on our cash flows, results of operations, financial position or liquidity.

In March 2006, the FASB issued SFAS No. 156, “Accounting for Servicing of Financial Assets—an Amendment of FASB Statement No. 140” (“SFAS No. 156”). SFAS No. 156 requires recognition of a servicing asset or a servicing liability each time an entity undertakes an obligation to service a financial asset by entering into a servicing contract. SFAS No. 156 also requires that all separately recognized servicing assets and servicing liabilities be initially measured at fair value and subsequently measured at fair value at each reporting date. SFAS No. 156 is effective as of the beginning of any entity’s first fiscal year that begins after September 15, 2006. We do not expect the adoption of SFAS No. 156 to have a material impact on our cash flows, results of operations, financial position or liquidity.

In June 2006, FASB issued FIN No. 48, “Accounting for Uncertainty Taxes”. The interpretation applies to all tax positions related to income taxes subject to FASB Statement No. 109, “Accounting for Income Taxes”. FIN No. 48 clarifies the accounting for uncertainty in income taxes by prescribing a minimum recognition threshold in determining if a tax position should be reflected in the financial statements. Only tax positions that meet the “more likely than not” recognition threshold may be recognized. The interpretation also provides guidance on classification, interest and penalties, accounting in interim periods, disclosure, and transition requirements for uncertain tax positions. FIN No. 48 will be effective for the Company’s fiscal year ending June 30, 2007. We do not believe that there are material tax positions that would result in a material impact upon implementation of FIN No. 48.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements”. This standard establishes a single authoritative definition of fair value, sets out a framework for measuring fair value and expands disclosures about fair 

value measurements. SFAS No. 157 applies to fair value measurements already required or permitted by existing standards. SFAS No. 157 will be effective for the Company’s fiscal year ending June 30, 2009. The Company is currently evaluating the requirements of SFAS No. 157 and has not yet determined the impact on its financial condition and results of operations.

In September 2006, the FASB issued SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and other Postretirement Plans - an amendment of FASB Statement No. 87, 88, 106 and 132R”. This pronouncement requires an employer to make certain recognitions, measurements, and disclosures regarding defined benefit postretirement plans. The Company does not have any defined benefit postretirement plans and SFAS No. 158 will not have any impact on its financial condition and results of operations.

In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 108 “Considering the Effects of Prior Year Misstatements in Current Year Financial Statements” (“SAB 108”). SAB 108 provides guidance on consideration of the effects of prior year misstatements in quantifying current year misstatements for the purpose

**Return to Table of Contents**

of a materiality assessment. SAB 108 is effective for fiscal years ending after November 15, 2006. The adoption of SAB 108 did not have an impact on the Company’s consolidated financial statements.

In February 2007, the FASB issued SFAS No 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”) which permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 will be effective for us on July 1, 2008. The Company is currently evaluating the impact of adopting SFAS 159 on its financial position, cash flows and results of operations.

RESULTS OF OPERATIONS FOR THE THREE MONTH PERIOD ENDING DECEMBER 31, 2007 COMPARED TO 2006

*Revenues:* Revenues from operations for the three month period ending December 31, 2009 and December 31, 2008 were $10,078 and $9,375 respectively . The increase was attributable to the commercial real estate held by Anton Nielsen Vojens.

*Selling, general and administrative expenses:*SG&A expenses for the three month period ending December 31, 2009 and December 31, 2008 were $ 378 and $753  respectively. The expenses are attributable to ANV's operations.

*Interest expense:*Interest expenses for the three month period ending December 31, 2009 and December 31, 2008 were $1,666 and $1,692 respectively. Interest expenses flucuations are attributable to the foreign currency conversion to the US Dollar.

*Other income (expense), net:* Other income (expenses) net for the three month period ending December 31, 2009 and December 31, 2008 were $0 for both periods. 

*Net income (loss) attributed to common stockholders:*Net loss and income for the three month period ending December 31, 2009 and December 31, 2008 attributed to common stockholders was $2,056 or $0.000 per share and $6,930, or $0.000 per share respectively.

*Liquidity and capital resources:*As of December 31, 2009 the Company had $42,331 in cash and cash equivalents and a working capital of $302,442 as compared to December 31, 2008 the Company had $174,812 in cash and cash equivalents and a working capital of $236,120. The change in cash is primarily due to the payments made on the debt of the acquisition of ANV and normal operations. The increase in the working capital is primarily related operations of ANV real estate and the reduction of debt associated with the ANV acquisition

Net cash from operating activities for three month period ending December 31, 2009 was (2,602), compared to net cash from operating activities as of December 31, 2008 was $7,438 . The net cash provided by operating activities was primarily due to the operations of ANV.

OFF BALANCE SHEET ARRANGEMENTS

We do not currently have any off balance sheet arrangements.

ACQUISITION EFFORTS:

The Company continues its efforts to raise capital to support operations and growth, and is actively searching acquisition or merger with another company that would complement AOXY or increase its earnings potential. During this period, the Company has been in discussion with Companies looking to be acquired. AOXY has not negotiated any terms nor proposed any acquisitions of any of these companies that have been accepted. In addition, the Company is in discussion with potential lending institutions to assist in financing any proposed acquisition. The Company expects difficulty in financing the growth of the increased business or acquisition and has been concentrating on raising capital and/or obtaining a line of credit.

HISTORICAL OPERATIONS:

**Return to Table of Contents**

				On March 9, 1998, pursuant to an Agreement for Purchase and Sale of Specified Business Assets ("Purchase Agreement"), a Promissory Note ("Note"),and a Security Agreement ("Security Agreement") all dated March 9, 1998, Advanced Oxygen Technologies, Inc. (the "Company") purchased certain tangible and intangible assets (the "Assets") including goodwill and rights under certain contracts, from Integrated Marketing Agency, Inc., a California Corporation ("IMA").

Pursuant to an employment agreement dated March 09, 1998 between the Company and John Teuber ("Employment Agreement"), on September 04, 1998 the Company terminated John Teuber for cause without relinquishing any of its rights or remedies. 

Pursuant to the Note, the Purchase Agreement, and the Security Agreement between the Company and ("IMA"), the Company on September 04, 1998 exercised its right of "Set Off" of the Note, as defined therein due to IMA's breach of numerous representations, warranties and covenants contained in the Note and certain ancillary documents. The Company further reserved any and all rights and remedies available to it under the Note, Purchase Agreement and Security Agreement. 

The Company entered into a two year employment agreement ("NAG Agreement" as contained in Exhibit I of the registrants SEC Form 10-K for the period ending June 30, 1998) with Nancy Gaylord on March 13, 1998. On September 18, 1998, Nancy Gaylord terminated her employment with the Company. The NAG Agreement had no provision for this termination. The Company entered into a lease agreement as contained in Exhibit I of the registrants SEC Form 10-QSB for the period ending December 31, 1998 with America-United Enterprises Inc. on October 01, 1998 and took possession of 4,700 sf. of premises on November 06,1998 in Santa Clarita for its CA location. Currently, this is the only California location of the Company. 

On December 9, 1998 the company delivered to IMA, "Notification to Indemnifying Party and Demand for Indemnification for $2,251,266." Pursuant to the Note, the Purchase Agreement, the Security Agreement, and the Employment Agreement (collectively the "Agreements"), the Company demanded that IMA pay $2,251,266 or defend the Company against the Liabilities (as defined therein) due to, among other things, IMA's breach, representations, warranties, and violation of the Agreements. 

On January 29, 1999, pursuant to the Purchase Agreement of 1/28/99, Advanced Oxygen Technologies, Inc. ("AOXY") purchased 1,670,000 shares of convertible preferred stock of Advanced Oxygen Technologies, Inc. ("STOCK") and a $550,000 promissory note issued by Advanced Oxygen Technologies, Inc. ("Note") from Integrated Marketing Agency, Inc. ("IMA"). The terms of the Purchase Agreement were: AOXY paid $15,000 to IMA, assumed a Citicorp Computer Equipment Lease, #010-0031648-001 from IMA, delivered to IMA certain tangible business property (as listed in Exhibit A of the Purchase Agreement), executed a one year $5,000 promissory note with IMA, and delivered to IMA a Request For Dismissal of case #PS003684 (restraining order) filed in Los Angeles county superior court. IMA sold, transferred, and delivered to AOXY the Stock and the Note. IMA sold, transferred, assigned and delivered the Note and the Stock to AOXY, executed documents with Citicorp Leasing, Inc. to effectuate an express assumption by AOXY of the obligation under lease #010-0031648-001 in the amount of $44,811.26, executed a UCC2 filing releasing UCC-1 filing #9807560696 filed by IMA on March 13, 1998, and delivered such documents as required. In addition, both IMA and AOXY provided mutual liability releases for the other. 

On April 18, 2000, notice was given that the Board of Directors and persons owning 64.7%, or 19,180,500 shares of common stock of Advanced Oxygen Technologies, Inc. have elected to adopt the following proposals: 1. To amend and restate the Company's Restated Articles of Incorporation to increase the Company's authorized Common Shares from 30,000,000 to 90,000,000 shares, 2. The Board of Directors has approved an amendment to the Company s Certificate of Incorporation to change the name of the Company to AOXY, Inc. The Company s current name was adopted in 1985 when the Company was focused on applications of its technology which it has since disposed of or otherwise abandoned. The Board of Directors believes it would be more appropriate for the Company to utilize a 

corporate name which more accurately describes the current focus of the Company or is not misleading as to the Company s operations. The above amendments to the Certificate of Incorporation will be filed with the Secretary of State of the State of Delaware, and the Name Change will become effective as of 5:00 p.m. Eastern Time, on the date of such filing.

On December 31, 2000, AOXY entered into an agreement with Eastern Star, ltd, and Baldwin Construction Co (the "Purchasers") whereby  the Purchasers will buy three million shares of capital stock of AOXY for one hundred and twenty five thousand dollars pursuant to a purchase agreement ("Purchase Agreement"). The Company has concluded the issuance and delivery of the shares pursuant to the Purchase Agreement. In addition, the Company received a request from Ann Sejeroe for a conversion of her 1 Preferred Share number P 0002 issued April 16, 1998, and in accordance with the restrictions, terms and conditions, as evidenced on the reverse side of the share certificate, the Company issued 333,333 shares bearing a restrictive legend.

**Return to Table of Contents**

The Company had a location in Santa Clarita, CA for operations. In 2000 the Company had abandoned this facility and equipment and maintained no staff other than the sole officer of the Company. Currently, the sole officer of the Company allows the Company to maintain its books, records and operations at its office.

On February 14, 2002 the Company gave notice of the change of the Company's location, and location of books and records from Advanced Oxygen Technologies, Inc. 26883 Ruether Avenue, Santa Clarita, CA, 91351 ("CA Location") to Advanced Oxygen Technologies, Inc. c/o Crossfield, Inc. 133 W 13th Street, Suite #5, New York, NY 10011, Telephone (212)-727-7085, Fax (208)-439-5488. This location is collocated with a related business of the president, Robert E. Wolfe.

The Company maintained a database ("Database") of business contacts that have participated in conference events. The Database was obtained through acquisition and the Company's activities of marketing events and producing CD-ROMS for clients. AOXY had a database management contract with Dun and Bradstreet, ("DB") and Walter Karl, Inc., a division of InfoUSA, Inc. ("WK") whereby, Walter Karl, Inc. will broker the Company's Database. Walter Karl's function was to market and rent the data contained in the Database. This was available in one of two formats: on a one time basis, or a 'database' basis whereby the customer will commit to a minimum number of contact names. The majority of the customers using the Database through WK were direct business to business marketers. WK received a fee for each sale. During the year ending June 30, 2002 Walter Karl was the Company s only source of revenue. During this period, Walter Karl was the Company s only customer. At the same time AOXY had an agreement with Dun and Bradstreet whereby DB would update, correct, append, and offer deletions to the Database. DB would evaluate the Database each time, and had the option to purchase contacts on a case by case as they saw fit, in which case AOXY would receive a fee. Correspondingly, should AOXY, rent, sell or otherwise profit from registered DB information, AOXY would pay a fee to DB.

At a special meeting of the Board of Directors, AOXY removed Joseph N. Noll as a director due to his inability to perform his duties as a director. AOXY appointed Kurt Sondergaard and Lawrence Donofrio to the board of directors to replace Joseph N. Noll . Kurt Sondergaard founder and major shareholder of the company, Mr. Sondergaard was educated in the Danish Navy as an electronic engineer. He has worked for 10 years in the electronic security industry, specifically in the IT sector. During this period, Kurt has developed as a business entrepreneur, building and selling an IT business. Lawrence Donofrio graduated from Hamilton College with a BA in English studies. He then worked at Citibank for three years as a financial analyst, and five years as a private financial consultant. He then took a position with Bankers Trust for two years and since 1982 has been a private consultant in the financial industry.

Pursuant to a stock acquisition on March 05, 2003 Advanced Oxygen Technologies, Inc. (AOXY or the Buyer) purchased 100% of the issued and outstanding stock of IP Services, ApS (IP or the Company) from all of its owners (the Shareholders) for value of five hundred thousand dollars (Purchase Price). AOXY issued fourteen million shares of common stock and one share of preferred convertible stock to the Shareholders for payment and consideration of the Purchase Price. Concurrently, pursuant to an Employment Agreement on March 05, 2003 AOXY entered into an agreement with Kurd Sondergaard (Employee). The Employee will be employed by AOXY for four years and will perform duties of president of IP, and AOXY and the Shareholders entered into a covenant of non competition agreement whereby the Shareholders agreed not to compete with IP for a period of five years.

Pursuant to a stock acquisition agreement, on February 3, 2006 Advanced Oxygen Technologies, Inc. ("AOXY") purchased 100.00% of the stock of Anton Nielsen Vojens ApS ("ANV"), a Danish company from Borkwood Development Ltd. (a previous shareholder of AOXY) for Six Hundred and Fifty Thousand US Dollars. ANV owns commercial real estate and produces rental income.

On August 1, 2006, the Company was notified by Bernstien & Pinchuk LLP that they had resigned as the Company's independent auditors. On September 12, 2006 the Company engaged Horwath Revisorenrne, AS Strandvejen 58, Hellerup, Denmark as its certified independent accounting firm/outside auditor.

On September 1, 2006 the Company sold its minority position of 20% of Mobile Group Inc. to KBA Holding ApS for one dollar.

On January 17 2007, the Company's location, and location of books and records has changed from Advanced Oxygen Technologies, Inc. C/O Crossfield Inc. 133 West 13th St. Suite #5 New York, NY 10011 ("Old Location") to Advanced Oxygen Technologies, Inc. c/o Crossfield, Inc. 100 Maiden Lane, Suite 2003, New York, NY 10038, Telephone (212)-727-7085, Fax (208)-439-5488. This location is co-located with a related business of the president, Robert E. Wolfe.

On March 5 2009, the Company's location, and location of books and records has changed from Advanced Oxygen Technologies, Inc. C/O 100 Maiden Lane, Suite 2003 New York, NY 10038 ("Old Location") to Advanced Oxygen Technologies, Inc. c/o Crossfield, Inc. 653 VT Route 12A, PO Box 189, Randolph VT 05060, Telephone (212)-727-7085, Fax (208)-439-5488. This location is co-located with a related business of the president, Robert E. Wolfe.

**ITEM 3. Quantitative and Qualitative Disclosures About Market Risk:**

Smaller reporting companies are not required to provide the information required by this Item.

**ITEM 4T. CONTROLS AND PROCEDURES**

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

**Return to Table of Contents**

We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer who is also our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Acting Chief Financial Officer concluded as of December 31, 2009 that our disclosure controls and procedures were effective at ensuring that the material information required to be disclosed in the Exchange Act reports is recorded, processed, summarized and reported as required in applicable SEC rules and forms.

During the quarter ended December 31, 2009, there were no changes in our internal control over financial reporting identified in connection with management’s evaluation of the effectiveness of our internal control over the financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
******************PART II**
**ITEM 1: LEGAL PROCEEDINGS**

There were no legal proceedings brought against the Company during this period. 

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

None**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None

**ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**

None

**ITEM 5. OTHER INFORMATION**

None

******ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K**

There were no reports filed on Form 8-K during the 3 month period ending December 31, 2009.

**EXHIBIT 99.906CERT (A)					CERTIFICATION OF CHIEF EXECUTIVE OFFICER					PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO					SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

**EXHIBIT 99.906CERT (B)					CERTIFICATION OF TREASURER					PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO					SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

**Return to Table of Contents**

**EXHIBIT 99.CERT (C)					CERTIFICATION PURSUANT TO					SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

**EXHIBIT 99.CERT (D)					CERTIFICATION PURSUANT TO					SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

SIGNATURE 

In accordance with the requirements of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

Date: February 5, 2010

 

/s/ Robert E. Wolfe /s/				------------------------------------------				Robert E. Wolfe, Chairman of the Board and				Chief Executive Officer and Principal				Financial Officer